Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amgen Inc.

Market Cap 192B 165B 152B 143B 268B 18,118B 271B 1,798B 702B 8,872B 719B 704B 30,701B P/E Ratio 2026 *
23.1x
P/E Ratio 2027 * 21x
Enterprise Value 233B 201B 185B 173B 326B 22,014B 329B 2,184B 853B 10,781B 874B 856B 37,304B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 5.85x
Free-Float
99.78%
Yield 2026 *
2.84%
Yield 2027 * 3%
1 day-1.21%
1 week-0.36%
Current month+6.86%
1 month+5.92%
3 months-4.66%
6 months+13.18%
Current year+9.22%
1 week 292.05
Extreme 292.05
309.4
1 month 276.45
Extreme 276.45
309.4
Current year 271.8
Extreme 271.8
333
1 year 230
Extreme 230
333
3 years 199.8
Extreme 199.8
333
5 years 174.58
Extreme 174.58
333
10 years 120.65
Extreme 120.65
333
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 67 01/01/2020
Chief Operating Officer 59 25/07/2016
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-0.36% - - 192B
-0.32%-1.72%+39.84%+148.79% 1,010B
-2.16%+1.51%+51.82%+43.93% 580B
-2.70%-0.66%+16.10%+63.07% 402B
-0.46%0.00%+21.28%+19.14% 330B
-1.52%+1.90%+23.73%+34.08% 281B
-1.95%-4.75%+20.15%+14.68% 280B
-0.57%+0.62%-44.67%-47.65% 197B
-0.38%-2.97%+12.15%+57.34% 156B
-0.80%+1.48%+6.56%-34.59% 149B
Average -1.06%+0.73%+16.33%+33.20% 376.27B
Weighted average by Cap. -1.00%+0.99%+26.63%+63.66%

Financials

2026 *2027 *
Net sales 37.79B 32.57B 29.98B 28.12B 52.83B 3,572B 53.36B 354B 138B 1,749B 142B 139B 6,053B 38.75B 33.4B 30.74B 28.84B 54.17B 3,662B 54.71B 363B 142B 1,794B 145B 142B 6,206B
Net income 8.26B 7.12B 6.56B 6.15B 11.55B 781B 11.67B 77.5B 30.27B 382B 31.01B 30.36B 1,324B 9.04B 7.79B 7.17B 6.73B 12.64B 854B 12.76B 84.78B 33.12B 418B 33.93B 33.21B 1,448B
Net Debt 41.23B 35.54B 32.71B 30.68B 57.64B 3,897B 58.21B 387B 151B 1,908B 155B 151B 6,603B 35.08B 30.24B 27.83B 26.11B 49.04B 3,316B 49.53B 329B 129B 1,624B 132B 129B 5,618B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
16/06/26 306.15 -0.05% 300
12/06/26 306.30 +0.92% 280
11/06/26 303.50 +1.02% 489
10/06/26 300.45 +0.40% 598
09/06/26 299.25 -0.33% 128
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
355.20USD
Average target price
352.50USD
Spread / Average Target
-0.76%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!